Research article · 17 Jul 2026
Conference abstractPublished 12 Nov 2013
Quality requirements for pharmaceutical product
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The quality assurance of pharmaceutical products is a wide-ranging concept covering all matters that individually or collectively influence the quality of a product. It is the totality of the arrangements made to ensure that pharmaceutical products are of the quality required for their intended use. Considerable developments in GMP have taken place in the intervening years and it has come to be realized that only controlling the quality of final products is no longer appropriate, since sampling test have statistically inherent limitation assuring the quality of pharmaceutical products and since the test items do not necessary cover all of the possible quality defects. This presentation ?Quality requirements of Pharmaceutical product? have two parts, of which part one outlines ?the general concepts of cGMP? as well as the principal components or subsystems of GMP. These include hygiene, validation, self-inspection, personnel, premises, equipment, materials and documentation. Part two outlines ?the basic concepts of Bioavailability and Bioequivalence? for generic formulation. These include Bio study protocol design, study execution and results evaluation. The focus points are regulatory requirements and quality assurance of the products to achieve the efficacy and desired safety. The approach is patient centric in each stage of production and patient safety is prime concern. Most importantly, emerging market is place where a lot of pharmaceutical business?s attraction besides a lot of changes is required in healthcare system which is extremely important for the region with special reference of all stake holders, pharmaceutical industries, healthcare & regulatory bodies and social sectors. The cGMP regulations and other quality management systems differ fairly in organization and in certain constituent elements; however, they are very similar and share underlying principles. For example, the cGMP regulations stress quality control. More recently developed are the quality systems stress quality management, quality assurance, and the use of risk management tools in addition to quality control. The QS working group decided that it would be very useful to examine exactly how the cGMP regulations and the elements of a modern, comprehensive quality system fit together in today's manufacturing world. Conclusion: Quality system is more comprehensive and applies throughout the different stages of product life cycle.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Developing Drugs.
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Soumah A. Qutob”

